Pharmacoeconomic Evaluation of Axitinib Introduction in Metastatic Renal Cell Carcinoma Treatment Scheme

Pharmacoeconomics: theory and practice
doi 10.30809/phe.3.2014.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moscow Pharmaceutical Society